发布时间:2019-04-20 09:54 原文链接: E.Z.N.A.®TotalRNAMidiKitProtocolDNaseIdigestionProtocol

实验概要

E.Z.N.A.®  Total RNA Midiprep Kit provides a rapid and easy method for the  isolation of up to 600 ug of total RNA from cultured eukaryotic cells,  tissues, or bacteria. The kit allows single or multiple, simultaneous  processing of samples in less than 40 min. Normally, 5 x 106 - 1 x 108 eukaryotic cells, 5 x 108-1 x 1010  bacterial cells, or 25- 200 mg tissue can be used in a single  experiment. There is no need for phenol/chloroform extractions, and  time-consuming steps such as CsCl gradient ultracentrifugation, and  precipitation with isopropanol or LiCl, are eliminated. While this kit  may be used for isolation of RNA from whole blood, we recommend you use  the E.Z.N.A.® Blood RNA Kit (product # R6614/R6615) as it is  specifically designed for effective hemolysis and hemoglobin removal and  gives higher RNA yields.

RNA purified using the E.Z.N.A.® Total RNA method is ready  for applications such as RT-PCR*, Northern blotting, poly A  RNA (mRNA)  purification, nuclease protection, and in vitro translation.

实验原理

The E.Z.N.A. Total RNA Midiprep Kits use the reversible binding properties of HiBind®  matrix, a new silica-based material. This is combined with the speed of  mini-column spin technology. A specifically formulated high salt buffer  system allows more than 600 ug of RNA molecules greater than 200 bases  to bind to the matrix. Cells or tissues are first lysed under denaturing  conditions that practically inactivate RNases. After the homogenization  process by either bead-milling or rotor-stator homogenizer, samples are  then applied to the HiBind® Midi spin columns to which total  RNA binds, after few quick washing step, cellular debris and other  contaminants are effectively washed away. High quality RNA is finally  eluted in DEPC-treated sterile water.

实验步骤

 Since HiBind®  RNA resin and spin-column technology actually removes most of DNA  without the DNase treatment, it is not necessary to do DNase digestion  for most downstream applications. However, certain sensitive RNA  applications might require further DNA removal. Following steps provide  on-membrane DNase I digestion:( see DNase I cat.# E1091for detail  information)
1. Follow the standard protocol until the samples  completely pass through the HiBind RNA column (step1-4). Prepare the  following:

    1) For each HiBind® RNA column, prepare the DNase I digestion reaction mix as follows:

    OBI DNase I Digestion Buffer 176 ul

    RNase-free DNase I (20 Kunitz unites/ul) 4 ul

    Total volume 180 ul

 Note:

       a. DNase I is very sensitive for physical denaturaion, so do  not vortex this DNase I mixture. Mix gently by inverting the tube.  Prepare the fresh DNase I digestion mixture before RNA isolation.

       b. OBI DNase I digestion buffer is supplied with OBI RNase-free Dnase set.

       c. Standard Dnase buffers are not compatible with on-membrane Dnase digestion.

    2) Pipet 180 ul of the DNase I digestion reaction mix directly onto the surface of HiBind®  RNA resin in each column. Make sure to pipet the Dnase I digestion  mixture directly onto the membrane. Dnase I digestion will not be  complete if some of the mix stick to the wall or the O-ring of the  HiBind® RNA column.

    3) Incubate at room temperature(25-30°C) for 15 minutes

2. Place column into a new 15 ml collection tube, and add 2 ml RNA  Wash Buffer I. Place the column at benchtop for 5 minutes. Centrifuge at  4,000-5,000 x g for 5 minutes and discard flow-through. Reuse the  collection tube in step 3.

3. Place column in the same 8ml collection tube, and add 2ml RNA Wash  Buffer II diluted with ethanol. Centrifuge at 4,000-5,000 x g for 5  minutes and discard flow-through. Reuse the collection tube in step 4.

Note: Wash Buffer II Concentrate must be diluted with absolute ethanol before use. Refer to label on bottle for directions.

4. Wash column with a second 2 ml of Wash Buffer II as in step 3.  Centrifuge and discard flow-through. Then with the collection tube  empty, centrifuge the spin cartridge for 5 min at 5000 x g to completely  dry the HiBind® matrix.

5. Elution of RNA. Transfer the column to a clean 15 ml microfuge  tube (not supplied with kit) and elute the RNA with 250- 500 ul of  DEPC-treated water (supplied with kit). Make sure to add water directly  onto column matrix. Let it stand for 1 minute. Centrifuge 3 min at 8000x  g to elute RNA. A second elution may be necessary if the expected yield  of RNA >50 ug.

Alternatively, RNA may be eluted with a greater volume of water.  While additional elutions increase total RNA yield, the concentration  will be lowered since more than 80% of RNA is recovered with the first  elution. Pre-heating the water to 70°C before adding to column and  incubating column 5 min at room temperature before centrifugation may  increase yields.


相关文章

“重现”原始地球RNA自然合成之路

现代生命离不开三样东西:DNA、蛋白质和RNA。但问题是,它们不可能同时出现。蛋白质就像建筑工人和建筑材料,没有蛋白质,DNA无法复制;DNA就像建筑蓝图,没有DNA,蛋白质无法构建。为了解开这个“先......

化学家首次实现RNA与氨基酸连接

据27日《自然》杂志报道,英国伦敦大学学院(UCL)化学家通过模拟早期地球的条件,首次实现了RNA与氨基酸的化学连接。这一难题自20世纪70年代以来一直困扰着科学家,如今,这一突破性成果为解答生命起源......

新活检方法用RNA识别早期癌症

美国芝加哥大学团队开发了一种更为灵敏的液体活检技术,该方法利用RNA而不是传统的DNA来检测癌症。这一创新方法在使用患者血液样本进行测试时,识别出早期结直肠癌的准确率达到95%,显著优于现有的非侵入性......

重大突破!新加坡发布长读长RNA测序数据集SGNEx

由新加坡科技研究局基因组研究所领导的科学家团队,发布了迄今全球最大、最全面的长读长RNA测序数据集之一——新加坡纳米孔表达数据集(SG-NEx)。这一成果有望解决疾病研究中长期存在的技术瓶颈,使研究人......

RNA技术研发与产业化项目获大学生创业基金资助

4月15日,中国工程院院士、中国科学院亚热带农业生态研究所首席研究员印遇龙领衔的单胃动物营养研究团队在科技合作和成果转化上取得新进展。其团队博士生王芳以“RNA技术研发与产业化应用”为主的项目,历经初......

学者开发MIRROR提高RNA编辑效率

近日,中山大学生命科学学院教授张锐团队首次提出名为MIRROR的全新内源性ADAR招募gRNA设计理念,显著提高了RNA编辑效率,这一突破为RNA编辑技术走向临床应用注入了强劲动力,同时也为相关疾病的......

科研人员发展环形RNA适配体技术为治疗阿尔茨海默病提供新策略

中国科学院分子细胞科学卓越创新中心陈玲玲研究组揭示了双链RNA依赖的蛋白激酶R(PKR)在阿尔茨海默病(AD)发生与进展过程中异常激活的分子病理特征,开发了基于具有分子内短双链结构环形RNA(ds-c......

华山医院检验科:发现新型RNA靶点,探索抗癌新策略

在癌症治疗领域,化疗药物耐药性问题一直是阻碍治疗效果提升的关键瓶颈。癌细胞拥有多种复杂的机制,能够巧妙地逃避化疗药物的“攻击”,其中,高活性的抗氧化系统可以有效减轻药物诱导的活性氧(ROS)损伤,成为......

DNA与RNA能协同互补调控基因表达

比利时布鲁塞尔自由大学主导的一项研究揭示,DNA和RNA的表观遗传学协同调控比过去想象的更加紧密。这项发表在最新一期《细胞》杂志上的研究,结合了DNA和RNA研究结果,指出这两种调控方式共同作用,形成......

学者发布RNA三维结构预测评估研究成果

近日,广州医科大学-中国科学院广州生物医药与健康研究院联合生命科学学院特聘教授、广州实验室研究员苗智超团队与合作者,对来自全球18个团队的预测进行了大规模评估,涉及23个RNA结构,包括RNA元件、适......